Cambridge, MA, May 3, 2023 (Globe Newswire) -- Cerevel Therapeutics has appointed Ron Renaud as its new CEO, succeeding Tony Coles, who will remain chairperson of the board. Renaud brings over 25 years of experience in biotech leadership, with prior CEO roles at companies such as Translate Bio and Idenix Pharmaceuticals.
Read full article here.
Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr
Zürich, Switzerland, November 16, 2023 (Business Wire) -- Memo Therapeutics AG (“MTx”), a late-stage biotech firm advancing top-tier therapeutic antibodies, discloses the appointment of Erik van den
Marlborough, MA, November 17, 2023 (PRNewswire) -- Boston Scientific Corporation (NYSE: BSX) announces the completion of its acquisition of Relievant Medsystems Inc., the sole provider of the FDA-cl
